Key result
Among 46 patients with decompensated heart failure, 25 received home parenteral diuretic therapy, which prevented hospital admissions and reduced symptom severity with no adverse events.
Why the study?
Does home-based parenteral diuretic treatment reduce symptoms and prevent hospital admissions in patients with decompensated end-stage heart failure?
Observational (n=46)
Does home-based parenteral diuretic treatment reduce symptoms and prevent hospital admissions in patients with decompensated end-stage heart failure?
Home-based parenteral diuretic therapy for decompensated heart failure is feasible, safe, and can prevent hospital admissions while improving symptoms.
Answers are grounded in this paper and cite their sources.
Supports home parenteral diuretic feasibility in end-stage HF; leaves open efficacy, safety, and scale validation in trials.
Referrals of 46 patients with decompensated end-stage heart failure were reviewed by a community heart-failure specialist nurse as part of a pilot study to determine patient numbers suitable for parenteral diuretic treatment at home, and the appropriateness of the Mini Nutritional Assessment (MNA), Edmonton Symptom Assessment System (ESAS) and Carer's Stress Scales. Triage of patients resulted in the following care pathways: 14 (30%) received intravenous therapy, 11 (24%) received subcutaneous therapy, 9 (20%) required adjustment of medication, 8 (17%) could not be treated because of limited staffing resource, 4 (9%) met study exemption criteria. There were no adverse events following furosemide infusion. The majority of intravenous and subcutaneous treatments took 1-7 days (total 187 days). Parenteral diuretic therapy prevented admissions and reduced the severity heart failure symptoms in particular oedema. Patients and carers appreciated the service, which had a positive effect on carers stress. Of the nursing tools, the ESAS and the Carer's Stress Scales proved useful in the management of patients.
No takes yet. Share an insight, caveat, or question.
Austin et al. (2013) conducted an observational in decompensated end-stage heart failure (n=46). Parenteral diuretic treatment at home was evaluated on Patient numbers suitable for parenteral diuretic treatment at home and appropriateness of nursing tools. Among 46 patients with decompensated heart failure, 25 received home parenteral diuretic therapy, which prevented hospital admissions and reduced symptom severity with no adverse events.
Synapse has enriched 10 related papers. Consider them for comparative context: